These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10980680

  • 1. Drug therapy in Behçet's disease.
    Okada AA.
    Ocul Immunol Inflamm; 2000 Jun; 8(2):85-91. PubMed ID: 10980680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S, Graziani G, Marcolongo R.
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
    Atmaca LS, Batioğlu F.
    Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Behçet's disease and immunosuppressive treatment. Our personal experience.
    Bietti GB, Cerulli L, Pivetti-Pezzi P.
    Mod Probl Ophthalmol; 1976 May; 16():314-23. PubMed ID: 55960
    [Abstract] [Full Text] [Related]

  • 9. [Behcet's disease therapy review].
    Vidaller Palacín A, Robert Olalla J, Sanuy Jiménez B, Rufi Rigau G, Folch Civit J, Charte González A.
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Huong du LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC.
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I, Deuter C, Stubiger N, Zierhut M.
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract] [Full Text] [Related]

  • 15. Fluorescein iris angiography and anterior segment fluorophotometry in patients with Behçet's disease.
    Yoshikawa K, Takahashi Y, Ohsone T, Wakatsuki Y, Kogure M.
    Jpn J Ophthalmol; 1987 Aug; 31(3):425-32. PubMed ID: 3430858
    [Abstract] [Full Text] [Related]

  • 16. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
    Zhao M, Wang H, Jiao X, Wei WB.
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapy of Behçet's disease.
    Kötter I, Dürk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M.
    Ger J Ophthalmol; 1996 Mar; 5(2):92-7. PubMed ID: 8741153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.